{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:37:13Z","timestamp":1790743033111,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"am","delay-in-days":416,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005737","name":"Universit\u00e9 Pierre et Marie Curie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019125","name":"Sorbonne Universit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jtos.2019.03.005","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T14:24:33Z","timestamp":1553178273000},"page":"516-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Correlation of clinical symptoms and signs with conjunctival gene expression in primary Sj\u00f6gren syndrome dry eye patients"],"prefix":"10.1016","volume":"17","author":[{"given":"H.","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kessal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Rabut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Daull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.","family":"Garrigue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2029-9591","authenticated-orcid":false,"given":"S.","family":"Melik Parsadaniantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1756-354X","authenticated-orcid":false,"given":"M.","family":"Docquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2006-5384","authenticated-orcid":false,"given":"C.","family":"Baudouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Brignole-Baudouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2019.03.005_bib1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2019.03.005_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clim.2017.04.003","article-title":"Innate immunity in Sj\u00f6gren's syndrome","volume":"182","author":"Kiripolsky","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jtos.2019.03.005_bib3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jtos.2014.12.001","article-title":"Clinical guidelines for management of dry eye associated with Sj\u00f6gren disease","volume":"13","author":"Foulks","year":"2015","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2019.03.005_bib4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/ICO.0b013e31826ef421","article-title":"Evaluation of tear osmolarity in non-Sj\u00f6gren and Sj\u00f6gren Syndrome dry eye patients with the TearLab system","volume":"32","author":"Lemp","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2019.03.005_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ophtha.2016.11.008","article-title":"Predictors of discordance between symptoms and signs in dry eye disease","volume":"124","author":"Vehof","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2019.03.005_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jtos.2013.07.003","article-title":"Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting","volume":"11","author":"Baudouin","year":"2013","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2019.03.005_bib7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","article-title":"Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction","volume":"100","author":"Baudouin","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2019.03.005_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.preteyeres.2012.02.003","article-title":"Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease","volume":"31","author":"Barabino","year":"2012","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jtos.2019.03.005_bib9","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1167\/iovs.11-9299","article-title":"Autoantibodies contribute to the immunopathogenesis of experimental dry eye disease","volume":"53","author":"Stern","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2019.03.005_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/aos.13436","article-title":"Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting","volume":"96","author":"Baudouin","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jtos.2019.03.005_bib11","doi-asserted-by":"crossref","first-page":"931","DOI":"10.21873\/invivo.11016","article-title":"Effect of autologous serum eye drops in patients with Sj\u00f6gren syndrome-related dry eye: clinical and in vivo confocal microscopy evaluation of the ocular surface","volume":"30","author":"Semeraro","year":"2016","journal-title":"In Vivo"},{"key":"10.1016\/j.jtos.2019.03.005_bib12","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/ICO.0000000000000542","article-title":"Effectiveness of autologous serum eye drops combined with punctal plugs for the treatment of Sj\u00f6gren syndrome-related dry eye","volume":"34","author":"Liu","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2019.03.005_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.gpb.2015.06.002","article-title":"Biomarkers for primary Sj\u00f6gren's syndrome","volume":"13","author":"Chen","year":"2015","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.jtos.2019.03.005_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ajo.2013.04.003","article-title":"Analysis of tear cytokines and clinical correlations in Sj\u00f6gren syndrome dry eye patients and non-Sj\u00f6gren syndrome dry eye patients","volume":"156","author":"Lee","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2019.03.005_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ajo.2015.09.039","article-title":"Clinical and molecular inflammatory response in Sj\u00f6gren syndrome-associated dry eye patients under desiccating stress","volume":"161","author":"L\u00f3pez-Miguel","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2019.03.005_bib16","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/ICO.0000000000000147","article-title":"Comparison of clinical efficacies of autologous serum eye drops in patients with primary and secondary Sj\u00f6gren syndrome","volume":"33","author":"Hwang","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2019.03.005_bib17","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2012-202565","article-title":"Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue","volume":"72","author":"Vitali","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtos.2019.03.005_bib18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"European study group on classification criteria for Sj\u00f6gren's syndrome. Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European consensus group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtos.2019.03.005_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European league against rheumatism classification criteria for primary Sj\u00f6gren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtos.2019.03.005_bib20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.jtos.2019.03.005_bib21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jaci.2005.05.033","article-title":"CCR 4 and CCR 5 expression in conjunctival specimens as differential markers of T(H)1\/T(H)2 in ocular surface disorders","volume":"116","author":"Baudouin","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jtos.2019.03.005_bib22","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1167\/iovs.09-4562","article-title":"Altered morphology and function of the lacrimal functional unit in protein kinase C{alpha} knockout mice","volume":"51","author":"Chen","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2019.03.005_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.exer.2013.03.018","article-title":"HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease","volume":"111","author":"Epstein","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2019.03.005_bib24","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1167\/iovs.15-16555","article-title":"Correlation between the inflammatory marker HLA-DR and signs and symptoms in moderate to severe dry eye disease","volume":"58","author":"Brignole-Baudouin","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2019.03.005_bib25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.exer.2003.08.005","article-title":"Flow cytometry in conjunctival impression cytology: a new tool for exploring ocular surface pathologies","volume":"78","author":"Brignole-Baudouin","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2019.03.005_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2249.2012.04587.x","article-title":"Cytokine\/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sj\u00f6gren's syndrome","volume":"169","author":"Moriyama","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jtos.2019.03.005_bib27","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.4049\/jimmunol.1201736","article-title":"Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function","volume":"189","author":"Degn","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2019.03.005_bib28","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1167\/iovs.12-11175","article-title":"Innate immune network in the retina activated by optic nerve crush","volume":"54","author":"Templeton","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2019.03.005_bib29","first-page":"341","article-title":"FasL and Bax genes are differentially expressed in acinar epithelium and inflammatory cells of primary Sj\u00f6gren salivary glands","volume":"94","author":"Badillo-Almaraz","year":"2003","journal-title":"Minerva Med"},{"key":"10.1016\/j.jtos.2019.03.005_bib30","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1167\/iovs.15-16736","article-title":"Gene expression-based predictive models of graft versus host disease-associated dry eye","volume":"56","author":"Cocho","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2019.03.005_bib31","doi-asserted-by":"crossref","first-page":"3573142","DOI":"10.1155\/2016\/3573142","article-title":"Clinical usefulness of monitoring expression levels of CCL24 (Eotaxin-2) mRNA on the ocular surface in patients with vernal keratoconjunctivitis and atopic keratoconjunctivitis","volume":"2016","author":"Shiraki","year":"2016","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.jtos.2019.03.005_bib32","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1167\/iovs.09-3425","article-title":"Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome","volume":"51","author":"Yoon","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2019.03.005_bib33","first-page":"2035","article-title":"Thioredoxin may exert a protective effect against tissue damage caused by oxidative stress in salivary glands of patients with Sj\u00f6gren's syndrome","volume":"34","author":"Kurimoto","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jtos.2019.03.005_bib34","doi-asserted-by":"crossref","first-page":"9486","DOI":"10.1523\/JNEUROSCI.1857-08.2008","article-title":"Reactive oxygen species derived from NOX1\/NADPH oxidase enhance inflammatory pain","volume":"28","author":"Ibi","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.jtos.2019.03.005_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ajo.2012.01.034","article-title":"Efficacy of topical blockade of interleukin-1 in experimental dry eye disease","volume":"154","author":"Okanobo","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2019.03.005_bib36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jamaophthalmol.2013.195","article-title":"Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial","volume":"131","author":"Amparo","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jtos.2019.03.005_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2015.10.008","article-title":"Sj\u00f6gren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin \u03b14 antagonist GW559090","volume":"143","author":"Contreras-Ruiz","year":"2016","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2019.03.005_bib38","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1073\/pnas.1217996110","article-title":"Design of a superior cytokine antagonist for topical ophthalmic use","volume":"110","author":"Hou","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtos.2019.03.005_bib39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jtos.2016.01.001","article-title":"Lifitegrast, a novel integrin antagonist for treatment of dry eye disease","volume":"14","author":"Perez","year":"2016","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2019.03.005_bib40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/0976-500X.195920","article-title":"Lifitegrast: a novel drug for treatment of dry eye disease","volume":"7","author":"Abidi","year":"2016","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1016\/j.jtos.2019.03.005_bib41","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2147\/OPTH.S117188","article-title":"Lifitegrast ophthalmic solution in the treatment of signs and symptoms of dry eye disease: design, development, and place in therapy","volume":"11","author":"Godin","year":"2017","journal-title":"Clin Ophthalmol"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012418302192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012418302192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:38:20Z","timestamp":1761539900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012418302192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1542012418302192"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2019.03.005","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation of clinical symptoms and signs with conjunctival gene expression in primary Sj\u00f6gren syndrome dry eye patients","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2019.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}